Dashboard
Manage Tickers

CRMDCorMedix Inc.

Nasdaq cormedix.com


na (na)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ na na (na)
DIA na na (na)
SPY na na (na)
TLT na na (na)
GLD na na (na)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-buy-on-cormedix-maintains-10-price-target
Needham Reiterates Buy on Cormedix, Mainta...
06/19/2024 09:45:49

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-receives-fda-support-for-expanded-indication-of-defencath-in-adult-tpn-patients-plans-to-submit-clinical-protocol-in-q3-2024-and-initiate-program-by-year-end
CorMedix Receives FDA Support for Expanded...
06/18/2024 12:20:28

cormedix-announces-cms-grants-pass-through-status-for-defencath-under-hospital-outpatient-prospective-payment-system-opps
CorMedix Announces CMS Grants Pass-Through...
06/06/2024 12:34:09

cormedix-announces-commercial-agreement-with-top-tier-dialysis-provider-for-the-supply-of-defencath
CorMedix Announces Commercial Agreement Wi...
05/28/2024 12:43:16

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

needham-reiterates-buy-on-cormedix-maintains-10-price-target
Needham Reiterates Buy on Cormedix, Mainta...
05/13/2024 09:32:37

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-q1-2024-gaap-eps-025-beats-028-estimate-cash-and-equivalents-of-586m
Cormedix Q1 2024 GAAP EPS $(0.25) Beats $(...
05/09/2024 11:36:03

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 1...

cormedix-inc-announces-cms-grants-transitional-drug-add-on-payment-to-defencath
CorMedix Inc. Announces CMS Grants Transit...
04/19/2024 12:31:44

cormedix-announces-us-inpatient-commercial-availability-of-defencath
CorMedix Announces U.S. Inpatient Commerci...
04/15/2024 12:40:19

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/12/2024 20:31:04

two-of-cormedix-abstracts-accepted-for-presentation-at-shea-conference
Two Of CorMedix Abstracts Accepted For Pre...
04/11/2024 12:37:54

jmp-securities-reiterates-market-outperform-on-cormedix-maintains-19-price-target
JMP Securities Reiterates Market Outperfor...
04/09/2024 12:39:35

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

needham-reiterates-buy-on-cormedix-maintains-10-price-target
Needham Reiterates Buy on Cormedix, Mainta...
04/09/2024 10:08:10

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-inc-announces-5-year-contract-with-dialysis-provider-arc-dialysis-for-the-supply-of-defencath
CorMedix Inc. Announces 5-Year Contract Wi...
04/08/2024 12:41:21

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

rbc-capital-maintains-outperform-on-cormedix-lowers-price-target-to-9
RBC Capital Maintains Outperform on Cormed...
03/13/2024 14:57:29

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $10 to...

needham-maintains-buy-on-cormedix-maintains-10-price-target
Needham Maintains Buy on Cormedix, Maintai...
03/12/2024 20:35:12

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-q4-gaap-eps-026-misses-020-estimate-cash-and-short-term-investments-of-76m
Cormedix Q4 GAAP EPS $(0.26) Misses $(0.20...
03/12/2024 11:33:04

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.20) by...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

cormedix-earnings-preview
Cormedix Earnings Preview
03/11/2024 18:01:18

truist-securities-maintains-buy-on-cormedix-lowers-price-target-to-14-report-released-on-30-january-2024
Truist Securities Maintains Buy on Cormedi...
01/31/2024 18:43:54

Truist Securities analyst Joon Lee maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $18 to $14.

cormedix-inc-announces-commercial-and-operational-updates-related-to-its-business-and-anticipated-launch-of-defencath
CorMedix Inc. Announces Commercial And Ope...
01/08/2024 13:54:31

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)